What does APOTHEEK DE RAEVE do?

APOTHEEK DE RAEVE is a pharmacy in Zutendaal. Private Limited, started on 18 January 1989, 1 establishment.

What is the address of APOTHEEK DE RAEVE?

The registered office of APOTHEEK DE RAEVE is located at Noordlaan 23, 3690 Zutendaal.

Is APOTHEEK DE RAEVE still active?

Yes. According to the CBE (31 October 2026) APOTHEEK DE RAEVE is active, legal situation “Normale toestand”, started on 18 January 1989.

Is APOTHEEK DE RAEVE registered on Peppol?

Yes, APOTHEEK DE RAEVE is registered on the Peppol network with ID 0208:0436564138.

What is the enterprise number of APOTHEEK DE RAEVE?

The enterprise number of APOTHEEK DE RAEVE is BE0436564138.

When was APOTHEEK DE RAEVE founded?

APOTHEEK DE RAEVE was founded on 18 January 1989.

Who are the directors of APOTHEEK DE RAEVE?

According to the 2025 annual accounts, the directors of APOTHEEK DE RAEVE are: TINA DE RAEVE.

Is APOTHEEK DE RAEVE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 January 1989; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK DE RAEVE make in 2025?

APOTHEEK DE RAEVE posted a profit after taxes of € 86,779 in financial year 2025.

What is the revenue of APOTHEEK DE RAEVE?

As a small company, APOTHEEK DE RAEVE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 276,804.

How much does an employee at APOTHEEK DE RAEVE earn?

The average wage cost per full-time employee at APOTHEEK DE RAEVE was € 42,000 in 2025: staff costs of € 92,473 for 2.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK DE RAEVE have?

According to the 2025 annual accounts, APOTHEEK DE RAEVE has 2.2 full-time equivalents (FTE).

APOTHEEK DE RAEVE (Private Limited) - Zutendaal

Dossier APOTHEEK DE RAEVE, printed on 1 November 2026 from databakkes.be/en/0436564138/apotheek-de-raeve. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK DE RAEVE from Zutendaal, company number BE0436564138, closed financial year 2025 with a result of € 86,779 after tax. For that financial year APOTHEEK DE RAEVE recorded a gross margin of € 276,804 and equity of € 487,085. Compared with financial year 2024, the result moved from € 122,895 to € 86,779. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.

What it is worth Growing

€ 487,085

▲ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 86,779

▼ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 223,185

▲ 18% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 35,000 paid out

40 % of the profit went to the shareholders, mostly to The T-Company (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.2

▲ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 92,473

▲ 23% vs 2024

€ 42,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,432

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 691,110

▼ 1% vs 2024

€ 36,183 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 152,905

▲ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,647

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 271,244 Gross margin 2022: € 271,244 First fiscal year in the series	€ 240,880 Gross margin 2023: € 240,880 ▼ 11% vs 2022 (€ 271,244) Unfavourable step	€ 321,448 Gross margin 2024: € 321,448 ▲ 33% vs 2023 (€ 240,880) Favourable step	€ 276,804 Gross margin 2025: € 276,804 ▼ 14% vs 2024 (€ 321,448) Unfavourable step	▼ 14%
Profit after taxes	€ 78,419 Profit after taxes 2022: € 78,419 First fiscal year in the series	€ 50,934 Profit after taxes 2023: € 50,934 ▼ 35% vs 2022 (€ 78,419) Unfavourable step	€ 122,895 Profit after taxes 2024: € 122,895 ▲ 141% vs 2023 (€ 50,934) Favourable step	€ 86,779 Profit after taxes 2025: € 86,779 ▼ 29% vs 2024 (€ 122,895) Unfavourable step	▼ 29%
Equity	€ 291,476 Equity 2022: € 291,476 First fiscal year in the series	€ 322,410 Equity 2023: € 322,410 ▲ 11% vs 2022 (€ 291,476) Favourable step	€ 435,305 Equity 2024: € 435,305 ▲ 35% vs 2023 (€ 322,410) Favourable step	€ 487,085 Equity 2025: € 487,085 ▲ 12% vs 2024 (€ 435,305) Favourable step	▲ 12%
Total debts	€ 969,307 Total debts 2022: € 969,307 First fiscal year in the series	€ 968,535 Total debts 2023: € 968,535 Unchanged (€ 969,307) Favourable step	€ 865,801 Total debts 2024: € 865,801 ▼ 11% vs 2023 (€ 968,535) Favourable step	€ 887,545 Total debts 2025: € 887,545 ▲ 3% vs 2024 (€ 865,801) Unfavourable step	▲ 3%
Cash	€ 134,746 Cash 2022: € 134,746 First fiscal year in the series	€ 148,856 Cash 2023: € 148,856 ▲ 10% vs 2022 (€ 134,746) Favourable step	€ 189,705 Cash 2024: € 189,705 ▲ 27% vs 2023 (€ 148,856) Favourable step	€ 223,185 Cash 2025: € 223,185 ▲ 18% vs 2024 (€ 189,705) Favourable step	▲ 18%
Land & buildings	€ 508,153 Land & buildings 2022: € 508,153 First fiscal year in the series	€ 514,921 Land & buildings 2023: € 514,921 ▲ 1% vs 2022 (€ 508,153) Unchanged	€ 488,559 Land & buildings 2024: € 488,559 ▼ 5% vs 2023 (€ 514,921) Unchanged	€ 503,118 Land & buildings 2025: € 503,118 ▲ 3% vs 2024 (€ 488,559) Unchanged	▲ 3%
Retained profit	€ 285,276 Retained profit 2022: € 285,276 First fiscal year in the series	€ 316,210 Retained profit 2023: € 316,210 ▲ 11% vs 2022 (€ 285,276) Favourable step	€ 429,105 Retained profit 2024: € 429,105 ▲ 36% vs 2023 (€ 316,210) Favourable step	€ 480,885 Retained profit 2025: € 480,885 ▲ 12% vs 2024 (€ 429,105) Favourable step	▲ 12%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 ▼ 33% vs 2022 (€ 30,000) Unchanged	€ 10,000 Dividend 2024: € 10,000 ▼ 50% vs 2023 (€ 20,000) Unchanged	€ 35,000 Dividend 2025: € 35,000 ▲ 250% vs 2024 (€ 10,000) Unchanged	▲ 250%
Bank debt	€ 764,914 Bank debt 2022: € 764,914 First fiscal year in the series	€ 737,028 Bank debt 2023: € 737,028 ▼ 4% vs 2022 (€ 764,914) Favourable step	€ 695,845 Bank debt 2024: € 695,845 ▼ 6% vs 2023 (€ 737,028) Favourable step	€ 691,110 Bank debt 2025: € 691,110 ▼ 1% vs 2024 (€ 695,845) Favourable step	▼ 1%
Balance sheet total	€ 1,260,783 Balance sheet total 2022: € 1,260,783 First fiscal year in the series	€ 1,290,944 Balance sheet total 2023: € 1,290,944 ▲ 2% vs 2022 (€ 1,260,783) Unchanged	€ 1,301,106 Balance sheet total 2024: € 1,301,106 ▲ 1% vs 2023 (€ 1,290,944) Unchanged	€ 1,374,629 Balance sheet total 2025: € 1,374,629 ▲ 6% vs 2024 (€ 1,301,106) Unchanged	▲ 6%
Employees (FTE)	2.2 Employees (FTE) 2022: 2.2 First fiscal year in the series	1.9 Employees (FTE) 2023: 1.9 ▼ 0.3 vs 2022 (2.2) Unchanged	1.8 Employees (FTE) 2024: 1.8 ▼ 0.1 vs 2023 (1.9) Unchanged	2.2 Employees (FTE) 2025: 2.2 ▲ 0.4 vs 2024 (1.8) Unchanged	▲ 0.4

Key figures of APOTHEEK DE RAEVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK DE RAEVE?

What happened at APOTHEEK DE RAEVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 29, 2026 New annual accounts for financial year 2025: profit of € 86,779 (▼ 29% vs 2024). filed late Source: NBB ↗
Feb 6, 1989 New establishment in Zutendaal. KBO
Jan 18, 1989 Start of the company according to the CBE. KBO

In short

From € 78,419 profit in 2022 to € 86,779 profit in 2025.

Paid € 124,228 in corporate taxes since 2022.

Best year ever: 2024, with € 122,895 profit.

On average € 125,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

The T-Company 100%

The stake of The T-Company comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK DE RAEVE

Behind APOTHEEK DE RAEVE is TINA DE RAEVE. The shares are held by The T-Company (100%).

Directors

According to the 2025 annual accounts

TINA DE RAEVE

Director

Also active at: The T-Company

Shareholders

The T-Company

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Noordlaan 23

3690 Zutendaal

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

The T-Company same network

€ 38,237 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0436.564.138

VAT number

BE 0436.564.138

Registered office

Noordlaan 23, 3690 Zutendaal

Names & denominations

APOTHEEK DE RAEVE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 January 1989

Peppol

Active · Active since 24 Sept 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DE RAEVE

Financials

What happened to APOTHEEK DE RAEVE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions